Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2026-01-24 @ 7:15 AM
Study NCT ID:
NCT01722968
Status:
COMPLETED
Last Update Posted:
2019-02-27
First Post:
2012-10-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Biomarker Study in Patients With HER2-negative Metastatic Breast Cancer Treated With Bevacizumab and Paclitaxel
Sponsor:
Theodoros Foukakis
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
EudraCT no: 2012-003743-30
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None